Screener
Revelation Biosciences, Inc. REVB Q2 2026 earnings
Reported August 7, 2026 · After market close
EPS-$0.87Beat by $0.01
EPS estimate-$0.88
Next report
Nov 5, 2026 (in 2 months)EPS estimate-$0.88
Versus estimates
Diluted EPS
FAQ
- When did Revelation Biosciences, Inc. report Q2 2026 earnings?
- Revelation Biosciences, Inc. (REVB) reported Q2 2026 earnings on August 7, 2026 after market close.
- What were Revelation Biosciences, Inc.'s Q2 2026 revenue and EPS?
- Revelation Biosciences, Inc. reported eps of $-0.87 for Q2 2026.
- Did Revelation Biosciences, Inc. beat estimates in Q2 2026?
- EPS beat the consensus estimate of $-0.88 by $0.01.
- How did Revelation Biosciences, Inc.'s Q2 2026 results compare year-over-year?
- Compared to the same quarter a year prior, eps grew 87.6% from $-7.01.
- Where can I find Revelation Biosciences, Inc.'s Q2 2026 SEC filings?
- You can read the 8-K earnings release (0001193125-26-338097) and the 10-Q periodic report (0001193125-26-337967) directly on SEC EDGAR. The filing index links above go to sec.gov.
